Literature DB >> 18167396

A 32-year-old woman with chronic abdominal pain.

Brian E Lacy1, Brooks D Cash.   

Abstract

Functional dyspepsia is a highly prevalent disorder that accounts for 5% of visits to primary care clinicians. It frequently coexists with other gastrointestinal tract disorders, including irritable bowel syndrome and gastroesophageal reflux disease. Symptoms of functional dyspepsia, including epigastric pain, early satiety, and postprandial nausea, are nonspecific, making its diagnosis difficult. Functional dyspepsia is a heterogeneous disorder involving a number of different pathophysiologic processes, culminating in both gastrointestinal sensory and motor dysfunction. Although functional dyspepsia does not impart any increased risks to long-term health, it significantly affects both individuals and society. The economic burden of evaluating and treating functional dyspepsia is estimated to be at least $1 billion per year, and patients with functional dyspepsia experience a markedly reduced quality of life. Using the case of Ms C, we apply an evidence-based approach to highlight current knowledge in the diagnosis, evaluation, and treatment of functional dyspepsia.

Entities:  

Mesh:

Year:  2008        PMID: 18167396     DOI: 10.1001/jama.2007.51-a

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

Review 2.  Review article: current treatment options and management of functional dyspepsia.

Authors:  B E Lacy; N J Talley; G R Locke; E P Bouras; J K DiBaise; H B El-Serag; B P Abraham; C W Howden; P Moayyedi; C Prather
Journal:  Aliment Pharmacol Ther       Date:  2012-05-16       Impact factor: 8.171

3.  Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.

Authors:  B E Lacy; Y A Saito; M Camilleri; E Bouras; J K DiBaise; L M Herrick; L A Szarka; K Tilkes; A R Zinsmeister; N J Talley
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

Review 4.  Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.

Authors:  Eamonn M M Quigley; Brian E Lacy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

5.  Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?

Authors:  Brian E Lacy; Scott L Gabbard; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

6.  Treatment of functional dyspepsia and gastroparesis.

Authors:  Benjamin Stein; Kelley K Everhart; Brian E Lacy
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

7.  Medication risk-taking behavior in functional dyspepsia patients.

Authors:  Brian E Lacy; Jerry Yu; Michael D Crowell
Journal:  Clin Transl Gastroenterol       Date:  2015-01-08       Impact factor: 4.488

8.  The effectiveness of cognitive behavior stress management on functional dyspepsia symptoms.

Authors:  Zahra Dehghanizade; Yadolah Zargar; Mahnaz Mehrabizadeh Honarmand; Ahmad Kadkhodaie; Majid Eydi Baygi
Journal:  J Adv Med Educ Prof       Date:  2015-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.